U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...

The Arkansas General Assembly gaveled in a new legislative session last month in Little Rock and members of both the House ...

President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

Influential media outlets have been circulating research from a shadowy group without disclosing its links to the pharmaceutical industry.

U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy ...

That's in part because they say pharmacy benefit managers, known as PBMs ... costs for Iowans and restrict options like mail-order pharmaceutical delivery that work best for some patients.

Senate Study Bill 1051 would shield agricultural chemical companies like Bayer, which produces the glyphosate-based herbicide ...

Avoiding a second trial, a former pharmaceutical rep who prosecutors said generated more than $10 million in wrongful insurance reimbursements pleaded guilty Tuesday to perjury in U.S. District Court.

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) ...

California insurers spent 11% more on pharmaceuticals in 2023 than in 2022 ... who don’t understand drug pricing schemes and restrictions set by pharmacy benefit managers. He’s had to turn away ...